WallStreetZenWallStreetZen

NASDAQ: TERN
Terns Pharmaceuticals Inc Stock Ownership - Who owns Terns Pharmaceuticals?

Insider buying vs selling

Have Terns Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Mark J. VignolaChief Financial Officer2023-11-30743$3.78
$2.81kBuy
Seokho Bryan YoonCOO and General Counsel2023-11-30743$3.78
$2.81kBuy
Senthil Vel SundaramChief Executive Officer2023-05-312,111$1.41
$2.98kBuy
Mark J. VignolaChief Financial Officer2023-05-319,997$1.41
$14.10kBuy
Seokho Bryan YoonCOO and General Counsel2023-05-319,997$1.41
$14.10kBuy

1 of 1

TERN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TERN insiders and whales buy or sell their stock.

TERN Shareholders

What type of owners hold Terns Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Opportunity LLC18.50%11,957,364$73.66MInsider
Orbimed Advisors LLC11.78%7,619,135$46.93MInstitution
Vivo Capital LLC10.30%6,657,992$41.01MInstitution
Deep Track Capital LP9.44%6,100,000$37.58MInstitution
Suvretta Capital Management LLC9.03%5,837,126$35.96MInstitution
Vr Adviser LLC6.96%4,497,117$27.70MInstitution
Hongbo Lu6.71%4,340,212$26.74MInsider
Blackrock Inc5.27%3,408,978$21.00MInstitution
Fmr LLC4.63%2,990,402$18.42MInstitution
Vivo Capital Viii LLC4.14%2,675,133$16.48MInsider

1 of 3

TERN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TERN72.17%27.83%Net Buying
STTK56.96%26.50%Net SellingNet Selling
CDMO90.48%9.03%Net SellingNet Selling
OCGN10.20%11.97%Net SellingNet Selling
LXEO60.65%25.62%Net Buying

Terns Pharmaceuticals Stock Ownership FAQ

Who owns Terns Pharmaceuticals?

Terns Pharmaceuticals (NASDAQ: TERN) is owned by 98.35% institutional shareholders, 37.92% Terns Pharmaceuticals insiders, and 0.00% retail investors. Vivo Opportunity LLC is the largest individual Terns Pharmaceuticals shareholder, owning 11.96M shares representing 18.50% of the company. Vivo Opportunity LLC's Terns Pharmaceuticals shares are currently valued at $78.44M.

If you're new to stock investing, here's how to buy Terns Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.